| Diabetes and cancer: a consensus report E Giovannucci, DM Harlan, MC Archer, RM Bergenstal, SM Gapstur, ... CA: a cancer journal for clinicians 60 (4), 207-221, 2010 | 3624 | 2010 |
| Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3 DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ... Journal of Clinical Oncology 36 (24), 2465-2472, 2018 | 1094 | 2018 |
| APOBEC3B is an enzymatic source of mutation in breast cancer MB Burns, L Lackey, MA Carpenter, A Rathore, AM Land, B Leonard, ... Nature 494 (7437), 366-370, 2013 | 919 | 2013 |
| Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth K Gupta, S Kshirsagar, L Chang, R Schwartz, PY Law, D Yee, RP Hebbel Cancer research 62 (15), 4491-4498, 2002 | 715 | 2002 |
| Effect of pembrolizumab plus neoadjuvant chemotherapy on pathologic complete response in women with early-stage breast cancer: an analysis of the ongoing phase 2 adaptively … R Nanda, MC Liu, C Yau, R Shatsky, L Pusztai, A Wallace, AJ Chien, ... JAMA oncology 6 (5), 676-684, 2020 | 640 | 2020 |
| Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins M Guix, AC Faber, SE Wang, MG Olivares, Y Song, S Qu, C Rinehart, ... The Journal of clinical investigation 118 (7), 2609-2619, 2008 | 638 | 2008 |
| Adaptive randomization of veliparib–carboplatin treatment in breast cancer HS Rugo, OI Olopade, A DeMichele, C Yau, LJ van’t Veer, MB Buxton, ... New England Journal of Medicine 375 (1), 23-34, 2016 | 615 | 2016 |
| Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer D Yee, S Paik, GS Lebovic, RR Marcus, RE Favoni, KJ Cullen, ... Molecular Endocrinology 3 (3), 509-517, 1989 | 519 | 1989 |
| Randomized controlled trial of weight training and lymphedema in breast cancer survivors RL Ahmed, W Thomas, D Yee, KH Schmitz Journal of Clinical Oncology 24 (18), 2765-2772, 2006 | 479 | 2006 |
| Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo AV Lee, JG Jackson, JL Gooch, SG Hilsenbeck, E Coronado-Heinsohn, ... Molecular endocrinology 13 (5), 787-796, 1999 | 445 | 1999 |
| Disrupting insulin-like growth factor signaling as a potential cancer therapy D Sachdev, D Yee Molecular cancer therapeutics 6 (1), 1-12, 2007 | 442 | 2007 |
| Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo 1H MR Spectroscopy—A Pilot Study at 4 T1 S Meisamy, PJ Bolan, EH Baker, RL Bliss, E Gulbahce, LI Everson, ... Radiology 233 (2), 424-431, 2004 | 436 | 2004 |
| The IGF system and breast cancer. D Sachdev, D Yee Endocrine-related cancer 8 (3), 197-209, 2001 | 423 | 2001 |
| Insulin-like growth factor receptor expression and function in human breast cancer KJ Cullen, D Yee, WS Sly, J Perdue, B Hampton, ME Lippman, N Rosen Cancer research 50 (1), 48-53, 1990 | 422 | 1990 |
| Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells S Avdulov, S Li, V Michalek, D Burrichter, M Peterson, DM Perlman, ... Cancer cell 5 (6), 553-563, 2004 | 419 | 2004 |
| Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins KH Schmitz, RL Ahmed, PJ Hannan, D Yee Cancer Epidemiology Biomarkers & Prevention 14 (7), 1672-1680, 2005 | 418 | 2005 |
| Adaptive randomization of neratinib in early breast cancer JW Park, MC Liu, D Yee, C Yau, LJ van’t Veer, WF Symmans, M Paoloni, ... New England Journal of Medicine 375 (1), 11-22, 2016 | 390 | 2016 |
| In vivo quantification of choline compounds in the breast with 1H MR spectroscopy PJ Bolan, S Meisamy, EH Baker, J Lin, T Emory, M Nelson, LI Everson, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2003 | 333 | 2003 |
| Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients C Yau, M Osdoit, M van der Noordaa, S Shad, J Wei, D de Croze, ... The Lancet Oncology 23 (1), 149-160, 2022 | 323 | 2022 |
| Insulin-like growth factor II mRNA expression in human breast cancer D Yee, KJ Cullen, S Paik, JF Perdue, B Hampton, A Schwartz, ... Cancer Research 48 (23), 6691-6696, 1988 | 312 | 1988 |
